Avalon BioVentures I, LP
Avalon BioVentures I, LP is a venture capital fund based in La Jolla, California. Its most recent Form D, filed Jul 22, 2021, reports no sales yet. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Tighe Reardon; Jay Lichter; Sanford Madigan.
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Tighe Reardon; Jay Lichter; Sanford Madigan
- Latest Form D
- Jul 22, 2021
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Avalon BioVentures I, LP
What is the minimum investment for Avalon BioVentures I, LP?
Avalon BioVentures I, LP's latest Form D, filed Jul 22, 2021, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Avalon BioVentures I, LP?
Avalon BioVentures I, LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Avalon BioVentures I, LP raised?
Avalon BioVentures I, LP's latest Form D, filed Jul 22, 2021, reports no sales yet.
Where is Avalon BioVentures I, LP based?
Avalon BioVentures I, LP is based in La Jolla, California.
Size compared with every venture capital fund
This fund hasn't reported any sales yet.